ALS Biopharma

ALS Biopharma LLC is an emerging biotechnology company focused on the discovery and development of small-molecule therapeutics and diagnostics for amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), a debilitating neurological orphan indication. The company leverages modern drug discovery methodologies, including compound library synthesis a... nd high-throughput screening, to identify novel treatment candidates. ALS Biopharma pursues both small-molecule and biologic protein-based therapeutic approaches through strategic partnerships with leading academic and industrial research laboratories. Based in Doylestown, Pennsylvania, the company operates laboratories at the Pennsylvania Biotechnology Center, which houses a comprehensive suite of chemistry and biochemistry instrumentation essential for contemporary molecular biology and medicinal chemistry work. The facility is equipped with real-time PCR systems, laminar flow hoods, table-top centrifuges, Thermofinnagan LCQ and ABI Qtrap mass spectrometers, Waters HPLC systems, a Biomek robotic liquid handler, and additional equipment supporting high-throughput screening and drug discovery operations. ALS Biopharma is affiliated with the Pennsylvania Drug Discovery Institute, strengthening its research capabilities and collaborative network. The company has demonstrated progress in advancing investigational compounds through regulatory pathways, with research collaborations focused on prodrug development in partnership with established pharmaceutical organizations. Through its integrated approach combining proprietary screening capabilities, specialized laboratory infrastructure, and collaborative partnerships with experienced pharmaceutical entities, ALS Biopharma is positioned to advance novel therapeutic options for patients suffering from ALS, addressing a significant unmet medical need in the treatment of this serious neurological condition.Read More